NeoGenomics, Inc.

Historical 13F Holders

Symbol
NEO
CUSIP
64049M209
All holders as of
Q2 2026
Type
Equity
Class
COM NEW
Reported Value, Excluding Options
Total Filings

13D/G Filers

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Every filing for 64049M209 since 12/18/2024, newest first.

Filer % of Class Filed
First Light Asset Management, LLC 13G/A Amendment 2
8.4% 8/14/2026
Event 6/30/2026
BlackRock, Inc. 13G/A Amendment 5 15.6% 7/30/2026
Event 6/30/2026
First Trust Portfolios L.P. 13G
7.8% 7/30/2026
Event 6/30/2026
Greenhouse Funds LLLP 13G/A Amendment 1
7.1% 5/15/2026
Event 3/31/2026
Millennium Management LLC 13G/A Amendment 1
1.7% 5/13/2026
Event 3/31/2026
First Light Asset Management, LLC 13G/A Amendment 1
10.8% 5/7/2026
Event 4/30/2026
Vanguard Capital Management LLC 13G 5.1% 4/30/2026
Event 3/31/2026
Vanguard Portfolio Management LLC 13G 5.9% 4/29/2026
Event 3/31/2026
Vanguard Group Inc 13G/A Amendment 6 0% 3/27/2026
Event 3/13/2026
Millennium Management LLC 13G
5.0% 12/9/2025
Event 12/2/2025
Millennium Management LLC 13G
4.97% 12/2/2025
Event 11/24/2025
BlackRock, Inc. 13G/A Amendment 4 14.6% 10/17/2025
Event 9/30/2025
First Light Asset Management, LLC 13G
7.6% 8/14/2025
Event 6/30/2025
Greenhouse Funds LLLP 13G
5.8% 8/13/2025
Event 6/30/2025
Integrated Core Strategies (US) LLC 13G/A Amendment 1
2.8% 7/17/2025
Event 6/30/2025
T. Rowe Price Investment Management, Inc. 13G/A Amendment 2 2.6% 5/14/2025
Event 3/31/2025
Integrated Core Strategies (US) LLC 13G
5.4% 3/18/2025
Event 3/13/2025
Janus Henderson Group PLC 13G/A Amendment 1 4.8% 2/14/2025
Event 12/31/2024

13F Holders by Quarter

Period Filings Shares, Excl. Options Value, Excl. Options
2026 Q3 9 57.5 k $1.05 M
2026 Q2 278 147 M $2.26 B
2026 Q1 264 134 M $996 M
2025 Q4 270 132 M $1.55 B
2025 Q3 266 130 M $1.00 B
2025 Q2 291 128 M $938 M
2025 Q1 271 126 M $1.20 B
2024 Q4 263 123 M $2.02 B
2024 Q3 283 124 M $1.83 B
2024 Q2 266 129 M $1.79 B
2024 Q1 277 133 M $2.09 B
2023 Q4 299 131 M $2.12 B
2023 Q3 294 120 M $1.49 B
2023 Q2 273 117 M $1.89 B
2023 Q1 269 116 M $2.02 B
2022 Q4 255 117 M $1.08 B
2022 Q3 258 119 M $1.02 B
2022 Q2 252 117 M $957 M
2022 Q1 296 112 M $1.36 B
2021 Q4 329 118 M $4.03 B
2021 Q3 343 116 M $5.58 B
2021 Q2 329 111 M $5.03 B
2021 Q1 354 108 M $5.21 B
2020 Q4 362 105 M $5.68 B
2020 Q3 312 102 M $3.77 B
2020 Q2 303 102 M $3.17 B
2020 Q1 286 95.5 M $2.64 B
2019 Q4 272 94.9 M $2.78 B
2019 Q3 269 87.4 M $1.67 B
2019 Q2 274 88.3 M $1.94 B
2019 Q1 248 80.9 M $1.66 B
2018 Q4 223 74.9 M $944 M
2018 Q3 181 79.6 M $1.22 B
2018 Q2 152 66.6 M $873 M
2018 Q1 140 67.3 M $549 M
2017 Q4 134 68.1 M $604 M
2017 Q3 142 67.1 M $737 M
2017 Q2 134 63.8 M $572 M
2017 Q1 145 61.4 M $485 M
2016 Q4 148 62.2 M $533 M
2016 Q3 143 59.9 M $492 M
2016 Q2 160 60.1 M $483 M
2016 Q1 125 56.6 M $382 M
2015 Q4 125 55.4 M $435 M
2015 Q3 101 38.4 M $220 M
2015 Q2 98 37.3 M $202 M
2015 Q1 86 34.1 M $159 M
2014 Q4 91 33.4 M $139 M
2014 Q3 91 33.6 M $175 M
2014 Q2 73 23.9 M $79.2 M
2014 Q1 73 23.8 M $82.4 M